Larson Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Buy
2,149
+127
+6% +$8.46K ﹤0.01% 993
2026
Q1
$127K Buy
2,022
+528
+35% +$36.8K ﹤0.01% 885
2025
Q4
$99.2K Sell
1,494
-82
-5% -$5.3K ﹤0.01% 934
2025
Q3
$106K Sell
1,576
-308
-16% -$24.4K ﹤0.01% 878
2025
Q2
$164K Sell
1,884
-443
-19% -$34.7K 0.01% 703
2025
Q1
$159K Buy
2,327
+1,852
+390% +$151K 0.01% 673
2024
Q4
$36.9K Buy
475
+137
+41% +$10.1K ﹤0.01% 994
2024
Q3
$22.7K Buy
338
+5
+2% +$411 ﹤0.01% 1153
2024
Q2
$37.8K Buy
333
+24
+8% +$3.03K ﹤0.01% 878
2024
Q1
$42.9K Hold
309
﹤0.01% 727
2023
Q4
$38.3K Buy
309
+1
+0.3% +$102 ﹤0.01% 704
2023
Q3
$28.7K Hold
308
﹤0.01% 735
2023
Q2
$39.6K Hold
308
﹤0.01% 603
2023
Q1
$35.8K Buy
308
+8
+3% +$896 ﹤0.01% 615
2022
Q4
$34K Hold
300
﹤0.01% 593
2022
Q3
$24K Buy
+300
New +$25.4K ﹤0.01% 589
2022
Q1
Sell
-12
Closed -$2K 1072
2021
Q4
$2K Buy
+12
New +$1.72K ﹤0.01% 940

Other funds holding DXCM

Larson Financial Group's DXCM Position: Q2 2026 in Review

Larson Financial Group increased its DexCom (DXCM) stake by 6.3% in Q2 2026, buying an estimated $8.46K and bringing the position to 2,149 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Larson Financial Group first reported a position in DXCM in Q4 2021 and has held it in 17 quarters since. The position peaked at $164K in Q2 2025. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Larson Financial Group held 2,149 shares of DexCom worth $145K as of Q2 2026.
  • Larson Financial Group bought 127 DexCom shares in Q2 2026, an estimated $8.46K.
  • DexCom made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #993 holding.
  • Larson Financial Group first reported a position in DexCom in Q4 2021 and has held it in 17 quarters since.
  • Larson Financial Group's DexCom position peaked at $164K in Q2 2025.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.